An immunoglobulin blood test measures the main antibody classes in serum—usually IgG, IgA, and IgM—to look for patterns of low antibody production or excessive immune-protein production. It is commonly ordered for recurrent or unusually severe infections, unexplained inflammation, chronic liver disease, abnormal total protein, suspected immune deficiency, or concern about a plasma-cell disorder. The panel does not show whether a person is immune to a specific infection; vaccine titers and pathogen-specific antibody tests answer that question. Low levels may result from an inherited or acquired immune deficiency, medication, protein loss, or a blood-cell disorder. High levels may reflect chronic infection, autoimmune activity, liver disease, or a monoclonal protein made by one plasma-cell clone. Each class has a different role, and the pattern matters more than a single flagged number. Age, laboratory method, symptoms, infection history, and related tests determine whether the finding is reassuring, needs repeat testing, or requires specialist evaluation.
- IgG provides most long-term circulating antibody protection, IgA guards mucosal surfaces, and IgM is prominent early in immune responses.
- Reference ranges vary by age and laboratory: children require age-specific intervals.
- Low IgG is usually the most important deficiency finding: vaccine responses and infection history help show whether it is clinically significant.
- High immunoglobulins may be polyclonal or monoclonal: protein electrophoresis helps distinguish the patterns.
- No fasting is usually needed: results are often reviewed with blood counts, kidney and liver tests, total protein, and SPEP.
Table of Contents
- What the Immunoglobulin Panel Measures
- Normal Ranges, Units, and Age Effects
- Low IgG, IgA, or IgM Patterns
- High IgG, IgA, or IgM Patterns
- How the Test Fits an Immune-Deficiency Evaluation
- Polyclonal Versus Monoclonal Increases
- Preparation and Reading the Report
- Follow-Up and Urgent Symptoms
What the Immunoglobulin Panel Measures
Immunoglobulins are antibodies made by plasma cells, which develop from B lymphocytes. A quantitative panel measures how much of each antibody class is present in serum. It does not identify the thousands of individual targets those antibodies recognize.
IgG
IgG is the most abundant immunoglobulin in blood and tissues. It supports long-term protection after infection or vaccination, neutralizes toxins and viruses, tags microbes for immune clearance, and can activate complement. IgG crosses the placenta and provides temporary protection to a newborn.
Total IgG is divided into four subclasses: IgG1, IgG2, IgG3, and IgG4. A normal total IgG can coexist with a clinically important subclass or vaccine-response problem, especially when recurrent bacterial respiratory infections continue. Subclass testing is not automatically needed for every low or normal result; it is most useful when the infection pattern supports it.
IgA
IgA protects mucosal surfaces in the respiratory and gastrointestinal tracts and is present in saliva, tears, breast milk, and other secretions. Serum IgA testing helps identify selective IgA deficiency and provides a quality check for IgA-based celiac tests. A total IgA blood test does not measure celiac-specific antibodies or secretory IgA function directly.
IgM
IgM is often the first antibody class produced during a new immune response. It is a large molecule that remains mainly in the bloodstream and is efficient at activating complement. Low IgM may occur as an isolated deficiency or as part of a broader antibody problem. High IgM may appear during infection, liver disease, autoimmune activity, or selected B-cell disorders.
The routine panel usually does not include IgE or IgD. IgE is ordered for allergy, parasitic infection, or selected immune disorders. IgD has limited routine use. Specific antibody titers, such as pneumococcal or tetanus antibodies, measure functional response to particular antigens rather than total antibody quantity.
Normal Ranges, Units, and Age Effects
Results are commonly reported in milligrams per deciliter (mg/dL) or grams per liter (g/L). Divide mg/dL by 100 to convert to g/L. Exact reference intervals differ by laboratory, instrument, and population.
Illustrative adult intervals often fall near:
- IgG: about 700–1,600 mg/dL
- IgA: about 70–400 mg/dL
- IgM: about 40–230 mg/dL
These are examples, not universal cutoffs. The range printed on the report should guide interpretation. A value considered low by one laboratory may sit inside another laboratory’s interval.
Children need age-specific ranges. Maternal IgG crosses the placenta, then falls during the first months of life before the infant’s production rises. IgA develops more slowly and may not reach adult levels until later childhood. Applying adult ranges to infants or young children can produce a false diagnosis of deficiency.
| Pattern | Possible meaning | Useful context |
|---|---|---|
| All within range | Major quantitative antibody deficiency is less likely | Specific vaccine responses or subclasses may still be abnormal |
| Low IgG with low IgA and/or IgM | Broad antibody deficiency, medication effect, protein loss, or lymphoid disorder | Repeat testing, vaccine titers, and secondary-cause evaluation are important |
| Very low IgA with normal IgG and IgM | Possible selective IgA deficiency | Age must be over 4 years and secondary causes excluded |
| One or more classes high | Polyclonal inflammation or monoclonal protein | SPEP and immunofixation help distinguish the pattern |
A mildly abnormal result can be temporary. Recent infection, hydration, pregnancy, medication changes, and normal biological variation can shift levels. A persistent pattern, a marked abnormality, or a result that matches significant symptoms deserves more attention than a one-time borderline flag.
What a normal panel does not rule out
A normal quantitative panel makes a major loss of circulating antibodies less likely, but it does not prove that every part of antibody immunity works normally. Total concentrations count antibody protein; they do not test how well antibodies recognize a particular vaccine antigen, neutralize a pathogen, or reach mucosal surfaces. A person with recurrent bacterial respiratory infections may therefore need pneumococcal serotype titers or other specific-antibody testing even when IgG, IgA, and IgM fall inside their intervals.
Normal total IgG can also mask an IgG-subclass deficiency, although subclass measurements should be interpreted cautiously. Subclass values fluctuate, age-specific ranges are essential, and a low result is most persuasive when it is reproducible and accompanied by poor vaccine responses and a compatible infection history. Conversely, a borderline low total immunoglobulin level in a healthy person with normal vaccine responses may not represent clinically important immune failure.
The panel also does not evaluate cellular immunity, complement function, neutrophil function, or the physical barriers that protect the lungs and gut. Recurrent infections can arise from asthma, airway anatomy, aspiration, cystic fibrosis, ciliary disorders, diabetes, medication exposure, or frequent contact with young children. The laboratory pattern must be interpreted within that broader differential diagnosis.
There is no evidence-based “optimal” level above the reference range. High antibody concentrations do not mean superior immunity. They may indicate sustained immune stimulation or abnormal plasma-cell production.
Low IgG, IgA, or IgM Patterns
Low immunoglobulins are called hypogammaglobulinemia when the overall gamma-globulin fraction is reduced. The pattern may be inherited, acquired, transient, or clinically insignificant.
Low IgG
IgG is the main quantitative marker in most significant antibody deficiencies. Low IgG can lead to recurrent sinusitis, ear infections, bronchitis, pneumonia, or infections with encapsulated bacteria. Some people also develop chronic diarrhea, giardiasis, bronchiectasis, autoimmune disease, enlarged lymph nodes, or granulomatous inflammation.
Possible causes include:
- Common variable immunodeficiency
- X-linked agammaglobulinemia or another genetic antibody disorder
- Medication effects, including some B-cell-depleting or immunosuppressive therapies
- Chronic lymphocytic leukemia, lymphoma, or another lymphoid disease
- Nephrotic syndrome or intestinal protein loss
- Severe burns or other major protein loss
- Treatment with certain anticonvulsants or immune-modifying drugs
- Temporary suppression after severe illness
A low IgG result does not by itself diagnose common variable immunodeficiency. CVID usually requires persistently low IgG, often low IgA and/or IgM, poor vaccine responses, a compatible clinical pattern, and exclusion of secondary causes. Age and timing matter because diagnostic criteria are not intended for young children with immature antibody production.
CVID can involve more than infections. Some patients develop autoimmune cytopenias, inflammatory bowel-like disease, interstitial lung disease, granulomas, enlarged spleen, lymph-node disease, or an increased risk of lymphoma. These complications may appear before recurrent infections become obvious. That is why a broad clinical review matters when several immunoglobulin classes are low or when low levels coexist with unexplained inflammation. The finding should not be dismissed simply because the patient has not had a dramatic pneumonia history.
Secondary hypogammaglobulinemia is more common than many inherited disorders in adults. The timing of the decline can provide a clue: a fall after anti-CD20 therapy, chemotherapy, stem-cell transplantation, major kidney protein loss, or onset of a lymphoid malignancy points toward an acquired cause. Clinicians often compare pre-treatment values, B-cell counts, albumin, urine protein, and infection frequency. Some medication-related reductions recover after treatment ends, whereas others persist and require long-term monitoring.
Low IgA
Very low IgA with normal IgG and IgM can fit selective IgA deficiency. Many affected people are healthy. Others have recurrent respiratory or intestinal infections, celiac disease, autoimmunity, or allergies. IgA deficiency can make tTG-IgA and other IgA-based celiac tests falsely negative, so IgG-based celiac serology may be needed.
A minority of people with severe IgA deficiency develop anti-IgA antibodies and may experience transfusion reactions. This is rare. A history of a serious reaction is more important than the low level alone and should be communicated to the blood bank.
Low IgM
Isolated low IgM is less common and more difficult to interpret. It may be associated with recurrent infections, autoimmune disease, or no symptoms. Secondary causes and broader immune testing should be reviewed before diagnosing selective IgM deficiency.
Low IgM plus low IgG suggests a broader antibody defect. In infants, low IgM may be interpreted differently because immune production changes rapidly with age.
Low immunoglobulins from protein loss
Antibodies can be lost through the kidneys or intestine even when the immune system produces them normally. Nephrotic syndrome causes heavy urinary protein loss and may reduce IgG. Protein-losing enteropathy can reduce several serum proteins. Albumin, urine protein, stool alpha-1 antitrypsin clearance, and clinical findings help identify these mechanisms.
High IgG, IgA, or IgM Patterns
High immunoglobulin levels are called hypergammaglobulinemia when the gamma fraction is increased. The elevation may be polyclonal, involving many antibody-producing cell groups, or monoclonal, involving one clone.
High IgG
Polyclonal IgG elevation can occur with chronic infection, autoimmune disease, chronic liver inflammation, sarcoidosis, and IgG4-related disease. Autoimmune hepatitis often produces a prominent IgG increase, but diagnosis requires liver enzymes, autoantibodies, exclusion of other causes, and sometimes biopsy.
Very high total IgG can increase blood viscosity in rare settings, but most moderate elevations do not cause symptoms directly. The underlying disease, not the IgG number, usually determines treatment.
High IgA
IgA may rise with alcohol-related or other chronic liver disease, inflammatory bowel disease, chronic infection, rheumatoid arthritis, lupus, IgA nephropathy, and IgA vasculitis. Serum IgA does not diagnose kidney IgA deposition. Urinalysis, kidney function, blood pressure, and sometimes biopsy are more direct.
A monoclonal IgA protein can occur in MGUS, smoldering myeloma, or multiple myeloma. Clues include anemia, kidney dysfunction, high calcium, bone pain, high total protein, weight loss, or an abnormal protein gap.
High IgM
IgM can rise during acute or chronic infection, primary biliary cholangitis, autoimmune disease, and some lymphoplasmacytic disorders. A monoclonal IgM protein can occur in IgM MGUS or Waldenström macroglobulinemia. Symptoms such as headaches, blurred vision, neuropathy, bleeding, enlarged lymph nodes, or marked fatigue may prompt evaluation for hyperviscosity or a clonal disorder.
Mixed elevations
Several classes rising together often suggests polyclonal immune activation. One class rising disproportionately, especially with a discrete band on electrophoresis, raises more concern for a monoclonal protein. Quantitative levels alone cannot make this distinction reliably.
How the Test Fits an Immune-Deficiency Evaluation
The panel is a screening test, not a complete assessment of immune function. Antibody quantity and antibody function are related but not identical.
A person can have normal IgG yet fail to make adequate antibodies to pneumococcal polysaccharides. Another person can have mildly low IgG but few infections and good vaccine responses. Infection history and functional testing determine whether treatment is needed.
When vaccine-response testing is used, clinicians measure antibodies before and several weeks after an indicated vaccine, then assess how many serotypes reached protective or appropriately increased levels. Interpretation is not a simple pass-or-fail percentage. It changes with age, the type and timing of prior pneumococcal vaccines, baseline titers, and the assay used. Testing should therefore be ordered and interpreted by a clinician familiar with antibody-deficiency criteria rather than by comparing a single titer with an internet cutoff.
Repeated measurements are also important because immunoglobulin levels can evolve. Some children with delayed antibody maturation improve with age. Adults with mild reductions may remain stable, recover after a secondary cause resolves, or gradually develop a clearer immune-deficiency phenotype. A trend that parallels recurrent infections or treatment exposure is often more informative than the lowest isolated result.
Features that strengthen concern for antibody deficiency include:
- Recurrent bacterial sinus, ear, or lung infections
- Two or more pneumonias or invasive bacterial infections
- Infections requiring intravenous antibiotics or hospitalization
- Chronic giardiasis or unexplained persistent diarrhea
- Bronchiectasis without another clear cause
- Poor response to routine vaccines
- A family history of primary immune deficiency
- Autoimmune cytopenias, enlarged spleen, granulomas, or chronic lymph-node enlargement with recurrent infections
An immunologist may order:
- Repeat quantitative IgG, IgA, and IgM
- Specific antibodies to tetanus, diphtheria, or pneumococcal serotypes
- Pre- and post-vaccination antibody testing
- IgG subclasses
- B-cell, T-cell, and natural killer cell counts
- Serum protein electrophoresis and immunofixation
- Genetic testing in selected cases
A pneumococcal antibody titer test can show whether the immune system responds to multiple serotypes. The interpretation depends on age, vaccine history, timing, and laboratory method.
Immunoglobulin replacement
Intravenous or subcutaneous immunoglobulin replacement supplies pooled IgG from donors. It is used for selected patients with clinically significant antibody deficiency, not simply for any low number. Treatment decisions consider infection burden, vaccine response, diagnosis, lung damage, and secondary causes.
Replacement raises measured IgG and changes how later values are interpreted. Clinicians may monitor trough levels, infection frequency, treatment tolerance, and organ complications. IgA and IgM are not substantially replaced by standard IgG products.
Polyclonal Versus Monoclonal Increases
Distinguishing polyclonal from monoclonal elevation is one of the most important uses of follow-up testing.
Polyclonal hypergammaglobulinemia means many plasma-cell clones are active. It usually appears as a broad increase in the gamma region on serum protein electrophoresis. Common causes include chronic infection, autoimmune or autoinflammatory disease, and liver disease.
Monoclonal gammopathy means one plasma-cell or B-cell clone produces a uniform immunoglobulin. It may appear as a narrow M spike. Possible diagnoses range from MGUS, which may remain stable for years, to multiple myeloma, Waldenström macroglobulinemia, amyloidosis, or lymphoma.
| Test | What it adds |
|---|---|
| Serum protein electrophoresis | Shows whether the protein rise is broad or forms a discrete band |
| Immunofixation | Identifies the heavy-chain class and light-chain type of a monoclonal protein |
| Free light chains and ratio | Assesses kappa and lambda production and may detect light-chain disease |
| Urine protein studies | Can identify monoclonal light chains or kidney protein loss |
| Blood count, calcium, and kidney function | Looks for organ effects associated with plasma-cell disorders |
The immunofixation blood test is more sensitive than SPEP for small monoclonal proteins. A normal quantitative panel does not entirely exclude a small clone, and a high panel does not prove one.
Preparation and Reading the Report
The test requires a routine blood draw. Fasting is usually not needed unless other ordered tests require it. Tell the clinician about recent infections, vaccinations, pregnancy, immune therapies, plasma transfusions, and immunoglobulin replacement.
Rituximab and other B-cell-depleting therapies can lower immunoglobulins over time. Corticosteroids and other immunosuppressive drugs may also affect results. Protein-losing conditions and major fluid shifts can change concentrations. Prescribed treatment should not be stopped solely to improve a test result.
Read the report in this order:
- Confirm the patient’s age and reference interval.
- Check the units.
- Review all three classes together.
- Compare with prior results from the same laboratory.
- Look at total protein, albumin, and globulin.
- Note whether SPEP or immunofixation was performed.
- Match the pattern with infections, inflammation, liver or kidney findings, and medication history.
A small change may not be clinically meaningful if the laboratory or method changed. Keeping the full report, not just the number, helps specialists compare results accurately.
The clinical question should also shape the comparison. When the test is used before immune-suppressing therapy, the baseline establishes whether low levels predated treatment. During immunoglobulin replacement, the measured IgG partly reflects infused donor antibody, so the timing of the blood draw relative to a dose matters. During follow-up of a monoclonal gammopathy, quantitative immunoglobulins may be reviewed for both the abnormal class and suppression of uninvolved classes, but electrophoresis, immunofixation, free light chains, and organ findings usually guide risk assessment more directly.
For children, serial results should be plotted against age-adjusted ranges rather than compared with an adult threshold. For older adults, new hypogammaglobulinemia may warrant review for medications and lymphoid disease even when the reduction is modest. In every age group, the purpose is not to normalize a number in isolation; it is to explain the pattern and reduce the risk of infection or organ injury.
Follow-Up and Urgent Symptoms
Abnormal results are usually confirmed and then investigated according to the pattern.
For low levels, clinicians may repeat the panel after recovery from acute illness, review medication timing, check urine and stool protein loss, measure vaccine responses, and refer to immunology. Recurrent pneumonia or bronchiectasis deserves prompt attention because preventing additional lung damage can change long-term outcomes.
For high levels, follow-up may include liver tests, infection screening, autoimmune evaluation, SPEP, immunofixation, free light chains, kidney tests, calcium, imaging, or hematology referral. A mildly elevated polyclonal pattern with an obvious inflammatory cause may simply be monitored as the underlying disease is treated.
Seek urgent care for high fever with confusion, stiff neck, breathing difficulty, signs of sepsis, or rapidly worsening infection—especially with known antibody deficiency. Also seek prompt assessment for severe bone pain, new weakness, reduced urine, chest pain, vision changes, unusual bleeding, or neurologic symptoms when a monoclonal protein or hyperviscosity is suspected.
Most flagged immunoglobulin results do not establish a serious diagnosis on their own. The useful information lies in the combination of IgG, IgA, IgM, protein pattern, vaccine response, and clinical history.
References
- Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-Analysis 2021 (Systematic Review)
- Common Variable Immunodeficiency 2025 (Review)
- Etiological study of polyclonal hypergammaglobulinemia in a French cohort of hospitalized patients and proposal of a diagnostic aid algorithm 2024
- Immunoglobulins Blood Test 2025 (Official Page)
- Polyclonal Gammopathy (Hypergammaglobulinemia) 2022 (Official Page)
- Overview: Immunoglobulins (IgG, IgA, and IgM), Serum 2025 (Official Page)
Disclaimer
Immunoglobulin ranges vary by age, laboratory, treatment status, and clinical setting. High or low IgG, IgA, or IgM requires interpretation with infection history, vaccine responses, protein studies, medications, and organ tests; severe infection, breathing difficulty, neurologic symptoms, or reduced urine needs urgent medical care.
